Production (Stage)
Twist Bioscience Corporation
TWST
$28.26
$0.100.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 92.79M | 88.71M | 84.71M | 81.46M | 75.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.79M | 88.71M | 84.71M | 81.46M | 75.30M |
| Cost of Revenue | 46.77M | 45.87M | 46.48M | 46.19M | 44.42M |
| Gross Profit | 46.03M | 42.84M | 38.23M | 35.27M | 30.88M |
| SG&A Expenses | 63.67M | 56.18M | 53.14M | 56.79M | 55.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 134.35M | 123.36M | 120.75M | 125.46M | 124.19M |
| Operating Income | -41.56M | -34.64M | -36.04M | -43.99M | -48.89M |
| Income Before Tax | -39.15M | -31.50M | -34.75M | -85.38M | -45.15M |
| Income Tax Expenses | 175.00K | 97.00K | -96.00K | 191.00K | 345.00K |
| Earnings from Continuing Operations | -39.33M | -31.59M | -34.66M | -85.57M | -45.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -39.33M | -31.59M | -34.66M | -85.57M | -45.49M |
| EBIT | -41.56M | -34.64M | -36.04M | -43.99M | -48.89M |
| EBITDA | -35.16M | -28.26M | -31.99M | -35.69M | -40.59M |
| EPS Basic | -0.66 | -0.53 | -0.59 | -1.47 | -0.79 |
| Normalized Basic EPS | -0.41 | -0.33 | -0.37 | -0.43 | -0.49 |
| EPS Diluted | -0.66 | -0.53 | -0.59 | -1.47 | -0.79 |
| Normalized Diluted EPS | -0.41 | -0.33 | -0.37 | -0.43 | -0.49 |
| Average Basic Shares Outstanding | 59.65M | 59.16M | 58.55M | 58.15M | 57.78M |
| Average Diluted Shares Outstanding | 59.65M | 59.16M | 58.55M | 58.15M | 57.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |